Across TCGA pan-cancer cohorts, RPL23AP39 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL23AP39’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPL23AP39 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL23AP39 is over-expressed in tumor.

LUAD and THCA are the cancer types where RPL23AP39 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP39 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.039	.034	1	view →
THCA	All	II,III,IV	+0.029	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL23AP39 RNA expression & survival · all RPL23AP39 data types